Skip to main content
Top
Published in: Diabetologia 1/2014

01-01-2014 | Letter

Risk stratification for diabetic eye screening

Authors: Irene M. Stratton, Steve J. Aldington

Published in: Diabetologia | Issue 1/2014

Login to get access

Excerpt

To the Editor: In the August issue of this journal Looker et al presented results from data analyses of patients from the Scottish Diabetic Retinopathy Screening programme [1]. The principal finding was that transition rates to referable diabetic eye disease were lowest among people with type 2 diabetes and who had had two consecutive screens showing no visible retinopathy. We had already published this result in Diabetes Care [2], online in November 2012 and in print in March 2013 but this has not been acknowledged by Looker et al. We recognise that our results were based on data from patients for whom we had no information on the type of diabetes, but they would predominantly have been patients with type 2 diabetes because they were from a population-based screening programme in England. The transition rates found in the Scottish study are of the same order as those found in our cohort. …
Literature
1.
go back to reference Looker HC, Nyangoma SO, Cromie DT et al (2013) Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 56:1716–1725PubMedCrossRef Looker HC, Nyangoma SO, Cromie DT et al (2013) Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 56:1716–1725PubMedCrossRef
2.
go back to reference Stratton IM, Aldington SJ, Taylor DJ et al (2013) A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care 36:580–585PubMedCrossRef Stratton IM, Aldington SJ, Taylor DJ et al (2013) A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care 36:580–585PubMedCrossRef
3.
go back to reference Goatman KA, Philip S, Fleming AD et al (2012) External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening Programme. Diabet Med 29:776–783PubMedCrossRef Goatman KA, Philip S, Fleming AD et al (2012) External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening Programme. Diabet Med 29:776–783PubMedCrossRef
Metadata
Title
Risk stratification for diabetic eye screening
Authors
Irene M. Stratton
Steve J. Aldington
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3060-4

Other articles of this Issue 1/2014

Diabetologia 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.